Intco Medical Technology Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Cash & Equivalents	5,964	5,948	12,014	7,222	5,033	5,003
Short-Term Investments	-	-	-	723.21	1,613	-
Trading Asset Securities	6,900	7,243	6,737	5,236	1,624	3,274
Cash & Short-Term Investments	12,864	13,191	18,751	13,181	8,270	8,277
Cash Growth	-38.70%	-29.65%	42.26%	59.39%	-0.09%	29.52%
Accounts Receivable	1,329	1,371	1,379	937.18	555.36	775.15
Other Receivables	22.4	46.08	78.33	41.89	80.93	30.6
Receivables	1,351	1,417	1,457	979.08	636.29	805.75
Inventory	1,694	1,327	1,265	1,150	1,004	1,079
Other Current Assets	521.14	363.99	480.62	292.93	325.23	600.95
Total Current Assets	16,430	16,299	21,955	15,603	10,235	10,763
Property, Plant & Equipment	11,609	11,607	9,790	9,246	8,911	8,262
Long-Term Investments	10,555	10,461	1,382	970.38	884.94	473.89
Other Intangible Assets	716.94	729.1	767.03	566.84	583.48	629.91
Long-Term Deferred Tax Assets	51.61	51.61	80.35	64.09	88.31	77.23
Long-Term Deferred Charges	4.84	4.92	5.22	1.84	1.76	2.9
Other Long-Term Assets	931.48	937.67	651.63	627.32	774.31	415.84
Total Assets	40,300	40,090	34,631	27,079	21,479	20,625
Accounts Payable	1,368	1,257	845.38	921.6	946.36	1,238
Accrued Expenses	120.54	234.47	215.38	174.47	201.53	194
Short-Term Debt	16,402	16,390	12,666	7,034	1,494	50.48
Current Portion of Long-Term Debt	917.55	701.44	436.37	53.4	29.04	34.29
Current Portion of Leases	-	-	-	1.94	4.01	2.64
Current Income Taxes Payable	165.29	116.41	65.18	15.64	9.63	37.5
Current Unearned Revenue	249.84	237	271.58	293.6	300.89	414.16
Other Current Liabilities	257.14	241.9	182.41	123.67	169.43	113.07
Total Current Liabilities	19,481	19,178	14,683	8,618	3,155	2,084
Long-Term Debt	322.89	409.29	166.8	77.25	51.59	201.26
Long-Term Leases	-	-	-	-	1.78	3.38
Long-Term Unearned Revenue	207.42	211.99	155.84	123.99	128.53	201.02
Long-Term Deferred Tax Liabilities	1,719	1,719	1,944	1,965	2,093	2,012
Total Liabilities	21,730	21,519	16,949	10,785	5,429	4,501
Common Stock	654.75	654.75	646.19	656	659.55	549.58
Additional Paid-In Capital	1,183	1,183	1,114	1,287	1,310	1,509
Retained Earnings	16,702	16,692	15,778	14,396	14,072	13,855
Treasury Stock	-239.12	-239.12	-133.47	-320.55	-253.81	-27.76
Comprehensive Income & Other	-50.71	-36.68	-0.38	10.63	18.79	-15.22
Total Common Equity	18,250	18,254	17,404	16,029	15,806	15,871
Minority Interest	319.59	318.06	277.6	265.99	242.93	252.25
Shareholders' Equity	18,569	18,572	17,682	16,295	16,049	16,123
Total Liabilities & Equity	40,300	40,090	34,631	27,079	21,479	20,625
Total Debt	17,643	17,501	13,269	7,166	1,580	292.05
Net Cash (Debt)	-4,778	-4,310	5,482	6,015	6,689	7,985
Net Cash Growth	-	-	-8.86%	-10.08%	-16.23%	30.68%
Net Cash Per Share	-7.85	-6.69	8.45	9.11	10.10	11.82
Filing Date Shares Outstanding	501.54	646.16	641.39	643.38	659.55	659.49
Total Common Shares Outstanding	501.54	646.16	641.39	643.38	659.55	659.49
Working Capital	-3,051	-2,879	7,272	6,985	7,080	8,679
Book Value Per Share	36.39	28.25	27.14	24.91	23.97	24.07
Tangible Book Value	17,533	17,525	16,637	15,462	15,223	15,241
Tangible Book Value Per Share	34.96	27.12	25.94	24.03	23.08	23.11
Land	-	11.72	11.72	11.72	11.52	10.55
Buildings	-	5,887	4,557	4,057	3,480	2,400
Machinery	-	8,471	6,624	5,613	4,986	4,247
Construction In Progress	-	803.11	1,288	1,509	1,705	2,326

Source: S&P Global Market Intelligence. Standard template. Financial Sources.